Provide challenges and struggles encountered when using e prescribing

Page history last edited by pjohnson@... 10 mos ago

Share your challenges, struggles and solutions by selecting the "Edit" tab above.  These may have been encountered during any point in the process of implementation or using e-prescribing.  You may also ask others to share how they addressed a situation that you are dealing with now.   "Save" your entry by clincking the "Save" button below. 

 

Comments:  At the bottom of this page is a "Comments" section that can be used to ask questions and begin a discussion on the entries.

Comments (3)

profile picture

Martin Kappeyne said

at 9:18 pm on Feb 26, 2009

Has anyone seen any ARRA (Stimulus) incentives for small and independent pharmacist who wish to accept ePrescribing orders?

profile picture

Martin Kappeyne said

at 5:40 pm on Jul 17, 2009

This week I talked with two local pharmacists. One using Nrx QS/1 likes it generally but complains that the current system deliveres orders that do not have a stated medication strength, or directions for the patient, or drug information. One would think that the ePrescribing software would ensure that this information is captured and properly delivered to the pharmacy so they do not have to do what they have always done: pick up the phone and get clarification. This is just a high tech way of delivering traditional problems!

The second pharmacist wouldn't consider the software because of the cost. His reimbursement was just recently cut from $2.25/prescribtion was cut to $1.75 and he was not going to give away another $0.25/prescribtion plus the cost of purchasing and maintaining the necessary hardware and software.

Overall, I see some major hurdles ahead.
1) Make ePrescribing and the pharmacy systems a lot more user friendly and cheap.
2) Eliminate dumb errors at the source.
3) Increase bidirectional communications between the pharmacy and the prescribing systems.

profile picture

Deanna Delancey, Business Analyst said

at 11:39 am on Jul 21, 2009

DEA regulations prohibiting electronic communication of schedule II-V drugs is a major issue. It's another example of legislation not keeping up with technology. I think it will be resolved eventually, but for now it is a source of frustration.

You don't have permission to comment on this page.

Printable version
 
Anonymous Create an account or Log in